Cargando…

Antibody-dependent enhancement and COVID-19: Moving toward acquittal

• Immunoglobulins represent an effective therapeutic option for the treatment of COVID-19. • Experimental findings of ADE with related coronaviruses provoked theoretical concerns of enhancing antibodies with COVID-19. • Emerging experimental and clinical data alleviate concerns and indorse the safet...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yager, Eric J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832065/ https://www.ncbi.nlm.nih.gov/pubmed/32526272 http://dx.doi.org/10.1016/j.clim.2020.108496

Ejemplares similares

Physician's acquittal of responsibility in Iranian statutes
por: Abbasi, Mahmoud, et al.
Publicado: (2011)

Acquittal of Dr. Warren C. Westlake
Publicado: (1877)

Maidstone—Acquittal of the Charge of Murder on the Ground of Insanity
Publicado: (1848)

Chelmsford—Charge of Murder—Acquittal on the Ground of Puerperal Insanity
Publicado: (1848)

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

Moving Towards ‘Goals of Care’ Plans for all Hospital Inpatients
por: Killeen, Emily, et al.
Publicado: (2021)

Is there antibody-dependent enhancement in SARS Coronavirus 2?
por: Kumar, Rohit, et al.
Publicado: (2020)

Is it time to move to systematic antithrombotic prophylaxis or therapy for all patients with COVID-19 disease?
por: Njonnou, Sylvain Raoul Simeni, et al.
Publicado: (2021)

COVID-19; beyond the obvious: how do we move forward?
por: Nasoodi, Afshin, et al.
Publicado: (2020)

Covid-19 and Tele-Health: Time to Move from Practice to Policy
por: Padhy, Susanta Kumar, et al.
Publicado: (2022)

Clinical case definition of COVID-19 and morbid obesity: Is it time to move on?
por: Valente, Marina, et al.
Publicado: (2021)

Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
por: Wang, Zhaoming, et al.
Publicado: (2021)

Moving forward: Ensuring quality research in vascular surgery during COVID-19
por: Ma, Xiya, et al.
Publicado: (2020)

Recommended Strategies to Move Closer Toward the Global Eradication of Polio: International Health Regulations
por: Shrivastava, Saurabh R., et al.
Publicado: (2016)

Perspectives on the Zika outbreak: herd immunity, antibody-dependent enhancement and vaccine
por: Silva, José Valter Joaquim, et al.
Publicado: (2017)

Ousted health care workers because of COVID-19 infection: Back to work is not an easy move
por: GOUEL-CHERON, Aurélie, et al.
Publicado: (2021)

Comment on moving toward targeting the right phenotype with the right platelet-rich plasma formulation for knee osteoarthritis
por: Sánchez, Mikel, et al.
Publicado: (2021)

Helmet CPAP: how an unfamiliar respiratory tool is moving into treatment options during COVID-19 in the US
por: Armirfarzan, Houman, et al.
Publicado: (2020)

Dealing with coronavirus disease 2019 (COVID-19) outbreaks in long-term care homes: A protocol for room moving and cohorting
por: Kain, Dylan C., et al.
Publicado: (2020)

Move the anesthesia workstation cautiously!
por: Dubey, Prakash K.
Publicado: (2014)

Cautious interpretation of antiphospholipid antibodies in COVID-19
por: Mehta, Sudhir, et al.
Publicado: (2020)

Endoscopy activity in a covid-19 high-risk area (Barcelona): Moving forward (or backwards) according to the necessary resources available
por: Uchima, Hugo, et al.
Publicado: (2020)

Endoscopy activity in a covid-19 high-risk area (Barcelona): Moving forward (or backwards) according to the necessary resources available
por: Uchima, Hugo, et al.
Publicado: (2020)

Vulnerability to Disasters: Are We Moving Ahead?
por: Shrivastava, Saurabh R, et al.
Publicado: (2012)

It is time to move forward into the era of Theranostics
por: Ahmadzadehfar, Hojjat, et al.
Publicado: (2018)

Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination
por: Flahault, Adrien, et al.
Publicado: (2022)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021)

Moving the Debate Forward in Right to Health Litigation
por: Ferraz, Octavio Luiz Motta
Publicado: (2016)

Modified Moving Average T-wave alternans cutpoints
por: Verrier, Richard L.
Publicado: (2021)

Child Telemental Health ‐ Moving Us Forward
por: Price, Maxwell Zachary, et al.
Publicado: (2021)

Depression, dependence and prices of the COVID-19-Crisis
por: Frank, Andreas, et al.
Publicado: (2020)

COVID-19 and mental disorders: Toward promotion of preventive care
por: Fond, G., et al.
Publicado: (2022)

Toward a unified pathophysiology in COVID-19 acute aortopathies
por: Roncati, Luca, et al.
Publicado: (2021)

Adiposity is the Crucial Enhancer of COVID-19
por: Yanai, Hidekatsu
Publicado: (2020)

Potential Use of Radiolabeled Antibodies for Imaging and Treatment of COVID-19
por: Dadachova, Ekaterina
Publicado: (2021)

COVID-19 Reinfection in An Immunosuppressed Patient Without An Antibody Response
por: Hunsinger, Dr. Hillary P., et al.
Publicado: (2021)

False-positive Legionella pneumophila antibodies in COVID-19 patients
por: He, Shu-hua, et al.
Publicado: (2023)

Comment on “Moving from Models to Mechanisms in Yoga Research”
por: Shivanna, Sushrutha
Publicado: (2020)

COVID-19: Social Irresponsibility of Teenagers Towards the Second Wave in Spain
por: Murillo-Llorente, Maria Teresa, et al.
Publicado: (2020)

COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view
por: Vitiello, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7e1g6r8vtkvf5tapnt425jvd6r